Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Taiho, Teikoku Form Alliance for Cancer Pain Reliever
July 12, 2012
- Teijin Pharma to Boost New Drug Ratio to More than 50%, Prepare “Post-Feburic” Products: President Arao
July 12, 2012
- Micro Marketing Method to Be Potentially Effective in Future: Ninomiya of Novartis Pharma
July 12, 2012
- Bayer HealthCare Initiates Multinational PIII Trial for Hemophilia A Treatment BAY94-9027
July 12, 2012
- Nippon Chemiphar Aiming to Boost Generic Drug Sales to 30 Billion Yen in FY2014: President Yamaguchi
July 12, 2012
- Shionogi Files Lawsuit against InterMune of US over Royalties Payment
July 12, 2012
- Astellas Transfers 2 APIs Including Psychotropic Agent to Maruishi
July 11, 2012
- Astellas Transfers 2 APIs Including Psychotropic Agent to Maruishi
July 11, 2012
- Halaven Fails to Meet Primary Endpoints vs Capecitabine in PIII Study: Eisai
July 11, 2012
- Suzuken to Offer Voluntary Early Retirement Program for Record 500 Employees
July 11, 2012
- BMKK Applies for Orencia SC Injection
July 11, 2012
- Takeda to Offer US Dollar Senior Notes for Repaying Debt for Nycomed Acquisition
July 11, 2012
- Taisho HD Acquires Mexican Pharmaceutical Companies to Enter OTC Drug Business
July 11, 2012
- Shionogi Launches First European Development Base
July 10, 2012
- Otsuka Licenses Digital Health Technology from Proteus of the US
July 10, 2012
- Astellas Launches RLS Treatment Regnite on July 10
July 10, 2012
- Pharmaceutical Companies Set Up Private Power Generators in Preparation for Planned Power Outages
July 9, 2012
- Ethical Drug Sales Up 9.7% in May, Pushed by 2 Extra Working Days: Crecon Report
July 9, 2012
- MTPC Launches Argatroban for HIT Type II in the UK
July 9, 2012
- Bayer Confident in Pipeline, Regards Japan as Strategically Important Country: Mr Fibig
July 6, 2012
ページ
Japanese Prime Minister Sanae Takaichi has pledged to respond to the US most-favored-nation (MFN) drug pricing policy to safeguard timely…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…